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Understanding the mechanisms underlying the pathophysiology of cerebral malaria in patients with Plasmodium
falciparum infection is necessary to implement new curative interventions. While autopsy-based studies shed some
light on several pathological events that are believed to be crucial in the development of this neurologic syndrome,
their investigative potential is limited and has not allowed the identification of causes of death in patients who
succumb to it. This can only be achieved by comparing features between patients who die from cerebral malaria
and those who survive. In this review, several alternative approaches recently developed to facilitate the comparison
of specific parameters between fatal, non-fatal cerebral malaria and uncomplicated malaria patients are described,
as well as their limitations. The emergence of neuroimaging as a revolutionary tool in identifying critical structural
and functional modifications of the brain during cerebral malaria is discussed and highly promising areas of clinical
research using magnetic resonance imaging are highlighted.
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Globally, an estimated 3.3 billion people were at risk of
malaria in 2011, with populations living in sub-Saharan
Africa representing approximately 80% of cases and 90%
of malaria-related deaths [1]. Plasmodium falciparum is
a major cause of morbidity and mortality worldwide.
Neurological complications are common in falciparum
malaria, but cerebral malaria (CM) is the most severe
and is associated with almost all neurocognitive seque-
lae. This complex and multi-factorial syndrome is char-
acterized by a potentially reversible encephalopathy with
coma and leads to a mortality rate of approximately
15%-25% even when appropriate treatment and intensive
care are provided. The fundamental pathogenesis of fatal
CM is still not well understood. However, several hy-
potheses have been advanced, including impaired tissue
perfusion due to mechanical obstruction of microvessels
by P. falciparum-parasitized red blood cells, hyper-
activation of host immune cells leading to the excessive* Correspondence: samuel.wassmer@nyumc.org
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unless otherwise stated.release of potentially harmful pro-inflammatory cytokines
[2-4], as well as coagulation dysfunction [5,6]. These
hypotheses may explain of some aspects of disease
pathogenesis, but they fail to explain the extent and re-
versibility of the coma associated with CM. Due to the
lack of specific neuro- or vasculoprotective therapies,
treatments are currently still limited to anti-malarial
drugs and emergency supportive care [7]. Elucidation of
key processes may suggest avenues for new interventions
that will improve the ability of clinicians to recognize CM
and decrease the mortality rate. The use of animal models
is helpful in exploring new hypotheses, but is limited as
most of the models do not approximate the disease closely
enough to allow extrapolations [8].
In this review, the limitations of approaches developed
recently to circumvent the problems of traditional path-
ology analyses are briefly described and the different
neuroimaging techniques used to date to investigate the
pathogenic mechanisms associated with the development
of CM are compiled, with a particular focus on the prom-
ising results obtained with magnetic resonance imaging
(MRI). In addition, pivotal areas of future research are
highlighted, with the aim of implementing new evidence-
based therapeutic avenues and improving outcomes.al Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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Post-mortem: the classical approach and its limitations
Historically, basic information regarding the pathogenesis
of CM has been generated by integrating autopsy findings
with clinical information gathered during life. For example,
Alphonse Laveran, who discovered the malaria parasite
[9], observed that the organ-specificity of the cerebral
syndrome corresponded to the burden of malaria para-
sites accumulated in the brain [10]. Detailed quantitative
histological studies later supported this relationship [11].
Marchiafava and Bignami deduced that parasite-infected
erythrocytes (IE) bind to endothelial surfaces, leading to the
reported sequestration [12]. Such clinico-histopathology
studies – some of them are still ongoing – have led to the
discovery of several pathological features that are believed
to be crucial in the development of CM [13-16].
However, the autopsy approach has major limitations.
With few exceptions, which include the Malaŵi series of
103 autopsies [14], the observations reported during
post-mortem studies in the field were obtained from a
small number of CM patients. This is largely due to the
colossal logistical and financial challenges involved in
maintaining a well-coordinated, long-term and multi-
disciplinary capacity to characterize patients clinically
prior to death, perform comprehensive autopsies, and
analyse the material collected during the post-mortems.
Second, cultural and/or religious taboos may increase the
reluctance of families to authorize autopsies, making it dif-
ficult to perform post-mortem analyses on large-scale in
some endemic areas. Indeed, while some of the pioneering
work in CM pathology was performed in South East Asia
[17-21], there is currently no extensive quantitative
clinico-histopathology study of adult CM ongoing in this
region. The largest reported repository of autopsy samples
in South East Asia was collected in Vietnam during the
mid-1990s [22-24], before the presence of retinopathy
was recognized as a crucial component of the accurate
diagnosis of both paediatric and adult CM [25-27]. Thus,
the extensive comparison of pathological findings between
carefully clinically defined African and Asian patients who
died of CM has not been possible so far.
Lastly, two inherent limitations of autopsy-based studies
of malaria now restrict our capacity to move beyond describ-
ing associations: i) data are generated from a single point in
time, precluding the identification of relevant pathogenic
processes; and ii) tissue is only available from individuals
who die, preventing any comparisons with survivors. Indeed,
without being able to compare those who survive to those
who die it is not possible to know if the observed pathology
in patients dying of CM is sufficient to cause death.
Alternative approaches: getting closer to the brain
In order to evade the limitations discussed above, tre-
mendous efforts have been made over the past decade todevelop novel and non- or minimally-invasive approaches,
allowing for the first time the comparison of specific
features between fatal CM and uncomplicated malaria
patients. For example, ex vivo techniques were recently
used to evaluate potential differences in endothelial
predisposition to activation by tumour necrosis factor
in paediatric patients from Malaŵi. Because endothelium of
the adipose tissue closely resembles cerebral endothelium
[28], it represents a useful ex-vivo model for examining
brain endothelial dysfunction in the context of CM [29].
Endothelial cells were, therefore, obtained from subcutane-
ous fat samples for analyses. This was efficiently performed
by needle aspiration biopsy on Malaŵian patients with
CM or uncomplicated malaria, a fast, simple and painless
procedure after the application of local anaesthetic [29].
Although the use of this model proved successful within
the parameters of the study, it presents obvious restric-
tions and the lack of tight junctions in the vasculature of
the adipose tissue does not allow the in-depth investiga-
tion of pathophysiological mechanisms believed to play a
key role in fatal paediatric CM. These include endothelial
injury, blood–brain barrier dismantlement and intracra-
nial hypertension [30,31].
Another example of an alternative advance is the use
of orthogonal polarization spectral (OPS) imaging to assess
the microcirculatory changes in mucosal surfaces during
malaria infection [32]. The clear images of sublingual and
rectal mucosa generated by the OPS device allowed for the
first time the visualization in vivo of microvessel obstruc-
tion by IE in adult patients with severe malaria, confirming
the evidence derived from pathological studies of fatal cases
[33]. While this model offers the advantage of a real time
intravital analysis of peripheral sequestration processes
that can be easily applied to both CM and uncompli-
cated malaria patients, it also presents limitations. In-
deed, the profile of expressed surface receptors is a key
determinant of endothelial function and this phenotype
differs markedly between organs [34]. The sequestration
observed in the mucosa of infected patients may there-
fore not reflect accurately what happens in the cerebral
microvessels, as those two vascular beds express different
receptors for IE.
This organ-specific endothelial phenotype pitfall was
elegantly circumvented by the examination of the retina in
malaria patients, a recent approach undertaken as part of
the redefinition of CM syndromes to increase the accuracy
of its diagnosis [35]. The retina is embryologically related
to the central nervous system and its microvasculature
displays an analogous cellular structure and blood-tissue
barrier. Its examination, therefore, provides a unique
opportunity to study the microvasculature of infected
patients and the effects of IE sequestration on neuro-
logic tissue in vivo. Ocular abnormalities, now known
as malarial retinopathy, were described in patients with
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adults [40,41]. When compared with less severe malaria pa-
tients, the prevalence and intensity of malarial retinopathy
was proportional to the intensity of the clinical syndrome
[26,42]. It has three main components: retinal whitening,
vessel changes and retinal haemorrhages. Retinal whitening
closely resembles the patchy ischemic retinal changes
in central vein occlusion [43] and matches areas of
hypo-perfusion, likely related to the presence of IE se-
questrated in the retinal microvasculature [44]. This
approach has proved critical in the accurate diagnosis
of CM [25,35] and although the presence of any one of
the three features of malaria retinopathy is sufficient to
make the diagnosis, retinal whitening is at present the
most sensitive and specific clinical indicator of cerebral
sequestration [45]. In addition, a recent analysis of the
optic nerve sheath by ultrasound allowed the measure
of increased intracranial pressure in Malaŵian children
with CM [46], a common feature of the syndrome. Despite
the knowledge leap afforded by retina examination during
life, the procedure presents investigative restrictions and
has not allowed the identification of the cause of death in
CM patients who succumbed. Indeed, the clinical findings
gathered through the eye examination to date do not
reflect the occurrence of potentially lethal cerebral
events associated with CM such as axonal injury [47],
nor do they allow the prediction of acute mortality in
comatose patients [48].
Neuroimaging during life: the answer to all the questions?
CM occurs predominantly in resource-poor settings, where
advanced medical imaging technologies are generally
unavailable. The emergence of neuroimaging as a tool
in elucidating the pathophysiology of the neurologic
syndrome has therefore been a long and tortuous process.
After being restricted to computed tomography (CT)
technology for a long time, neuroimaging studies recently
started to use MRI approaches on a large scale to enhance
the clinical characterization of the disease. Globally, the
use of more sophisticated investigative and non-invasive
medical imaging technologies could transform our under-
standing of pathophysiological derangements in critical
illness and result in substantial improvements in acute
management of patients with CM.
Computed tomography: a first step
CT scans are now commonly available, do not require a
challenging infrastructure, are cheap to run and allow a
snapshot of the patient’s brain in less than a minute. In
addition, contrast material can be administered to in-
crease conspicuity of vascular lesions and breakdown of
the blood brain barrier. The first report of the use of CT
in malaria patients was published in 1983 and scans of
the brain in 10 Thai adult patients with CM revealedmixed results. Evidence of cerebral oedema was only de-
tected during the agonal phases in two adults, while four
patients had completely normal scans. The authors
concluded that oedema might occur in CM but cannot
always explain the occurrence of coma in patients [49].
After a hiatus of over a decade, a similar study was per-
formed in 14 African children with CM. CT was carried
out both during the recovery phase and at follow-up and
similar discrepancies were observed, albeit at a higher
ratio. Six children had diffuse brain swelling and eight
patients exhibited normal scans [50]. These differences
might be explained by the rapid resolution of brain
swelling in children, coupled to the late monitoring of
CT changes. As part of a subsequent study in India, 21
patients diagnosed with CM underwent both non-
enhanced and contrast CT. The occurrence of diffuse
brain swelling was observed in 42% of the patients and
was associated with a poor prognosis, whereas no deaths
were recorded in patients with normal CT findings [51].
Finally, the recent CT monitoring of a larger cohort of
126 Indian patients with CM revealed that brain swelling
is the most common finding associated with the path-
ology. Indeed, 63% of the patients had cerebral swelling,
the amplitude of which was not, however, related to coma
depth or mortality [52].
CT scans have certainly illuminated some of the patho-
logical changes associated with CM in both adult and
paediatric patients but there is no unanimity regarding the
occurrence of brain swelling or its role in the induction of
coma. Such discrepancies could be due to the overall small
number of patients enrolled, the lack of controlled studies,
the different points at which CT scans have been performed
or the absence of contrast enhancement in the largest
series. In addition, none of these studies incorporated the
presence of retinopathy as a diagnostic tool for CM and
might, therefore, have included a substantial proportion of
patients with non-malarial central nervous system disorders
[25]. Indeed, a study performed in Malaŵi and restricted to
retinopathy-positive CM patients demonstrated that acute
CT scans reveal findings consistent with autopsy reports,
and that the presence of diffuse brain swelling, whether
it involves the brainstem or not, was associated with
protracted coma and death [53].
The most consistent finding in all the studies is the
presence of brain swelling in some CM patients (Figure 1).
This could be attributed to the increased blood volume in
the brain following the sequestration of IE, but also to the
accumulation of intra-cellular fluid due to impaired cellu-
lar metabolism (cytotoxic oedema) and the accretion of
interstitial fluid in brain tissue following a breakdown of
the blood–brain barrier (vasogenic oedema). It is likely
that these mechanisms are linked, since cytoadherence of
IE to endothelial cells has been shown to compromise the
functional integrity of the blood–brain barrier [54]. The
Figure 1 CT scans of adult CM patients from India showing mild to severe brain swelling. Non-enhanced 8 mm transverse sections of a
control patient (A) and two acute CM patients showing mild and severe cerebral oedema (B and C, respectively). Images were obtained within
6 hours of admission at Ispat General Hospital in Rourkela, Orissa, India, as part of another study [52] and using a Philips W1000 third generation
CT scan. Brain swelling observed in (B) and (C) was defined as loss of cerebrospinal fluid space, small ventricles, absence of sulci, and/or compression of
the cisterns. Mild brain swelling was defined as local or diffuse effacement of sulci and Sylvian fissure without compression of the supratentorial ventricular
system (B). Severe swelling was defined as diffuse obliteration of sulci, Sylvian fissure and basal cisterns, together with an important mass effect causing
near total obliteration of the supratentorial ventricular system and generalized hypodensity of brain parenchyma (C).
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study of CM pathophysiology is the inability to distinguish
vasogenic from cytotoxic oedema. This distinction can,
however, be made by diffusion-weighted MRI scanning
and is crucial to shed light on the possible mechanisms
that may be leading to brain swelling in CM, as well as
evaluate new therapeutic avenues.
Magnetic resonance imaging – the finish line?
MRI is a powerful diagnostic tool for monitoring and
understanding key features involved in the progression
of neurologic diseases. It was, therefore, identified as the
most promising imaging modality for visualization of
CM pathology in vivo [55,56]. However, this approach
has been mainly restricted to animal models of CM
and until recently, almost all clinical MRI studies have
involved a single case report of small series of patients
[57-62]. These reports presented variable results, which can
be attributed to the low number of patients involved in the
studies, the non-specific neurological manifestations gener-
ated by the diffuse involvement of the brain, the variation
in patient age and the evolution of MRI techniques and
resolution over the years.
The first MRI study of a large series of patients with
malaria living in an endemic area was performed in
Thailand in 1995 in adults using a 0.2 Tesla scanner. It
revealed that increased brain volume and swelling was
common in patients with CM, but this difference was at-
tributed to an increase of the volume of intracerebral
blood caused by sequestration of IE rather than cerebral
oedema [63]. MRI techniques have developed substantially
since the publication of these results and clinical MRI
technology is now available in several endemic countries.
MRI in resource-limited settings is challenging due to spe-
cific infrastructure requirements including sufficient foun-
dation to withstand the heavy magnet, continuous power
supply, steady climate control, access to helium, and digitalimage archiving capabilities [64]. Despite these challenges,
several MRI centers have been successfully installed and
can be used to enhance the clinical characterization of
patients with CM through application of neurological
MRI methods. A milestone in this approach was reached
in June 2008, when a 0.35 Tesla MRI unit became avail-
able in Malaŵi, leading to the largest prospective study of
paediatric CM ever undertaken to date [65]. Indeed, the
use of a low-field permanent magnet MRI is a solution
to some of the hindrances stated above, in particular
frequent power outages and the unpredictable availability
of cryogens could result in the quenching of a high field
superconducting magnet. Initially, 152 children with acute
CM were enrolled and 120 children meeting a stringent
retinopathy-positive definition of CM were compared
to 32 retinopathy-negative CM patients. A wide range
of structural abnormalities was identified in the brain of the
retinopathy-positive group, which is consistent with the
high variability of findings reported at autopsy [14]. The
significant findings included basal ganglia changes, white
matter changes, pons and brainstem changes in addition
to diffuse cortical involvement. The disease affected the
posterior fossa less frequently. This descriptive study did
not focus on clinical correlates beyond retinopathy status,
but a moderate to severe increase in brain volume was
identified as the single most important discriminator
between retinopathy-positive and retinopathy-negative
patients (Figure 2). Interesting and unusual patterns of
restricted diffusion were reported in the retinopathy-
positive group in various sub-segments of the brain [65].
This first study had several limiting factors, including
the absence of serial analyses, which is presently underway,
and an unexpected inability to detect contrast agent. Since
MRI routinely shows contrast enhancement at low fields,
the lack of such a finding may be related to the status of
the blood-brain barrier during paediatric CM. Further re-
search into the integrity of this permeability barrier as a
Figure 2 MRI of paediatric patient with fatal CM from Malaŵi presenting severe brain swelling. Admission axial T2 scan (TR 3140, TE 123)
of a 4 years old male child with fatal retinopathy-positive CM performed at Queen Elizabeth Central Hospital in Blantyre, Malaŵi (A). Severe brain
swelling is observed, with complete loss of sulcal markings. (B) shows a lower slice depicting severe brainstem compression resulting from the
swelling. A mid-sagittal T1 Flair image (TR 2311, TE 26, ET 2) of the same patient reveals the complete effacement of all basilar cisterns and the
4th ventricle, as well as severe brainstem compression (C). Finally, (D) shows potential diffuse restricted diffusion in the cerebral cortex and white
matter. The child succumbed from respiratory failure 3 hours after these images were obtained.
Figure 3 MRI of paediatric CM survivor from Malaŵi during the
acute phase and at follow-up. Admission axial T2 scan (TR2960, TE122)
of a 2 years old male Malaŵian child with retinopathy-positive CM
performed at Queen Elizabeth Central Hospital in Blantyre, Malaŵi. There
is severe brain swelling with total loss of sulcal markings and grey-white
differentiation (A). The same child presents mild diffuse atrophy one
month later during the post-discharge follow-up visit (B).
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using contrast in paediatric CM patients on the high field
MRI located in neighboring Zambia. Further research into
the integrity of this permeability barrier as a source for
non-enhancement is presently being undertaken using con-
trast in paediatric CM patients on the high field MRI lo-
cated in neighbouring Zambia. However, the results
generated are in line with previous reports in adult CM
MRIs [58] and CT scans in both paediatric [50] and adult
patients [51,52], suggesting that increased brain volume
may be a common feature in CM, and that it may be impli-
cated in the pathogenesis of death in patients with CM.
This could also explain its reversibility, as brain swelling de-
creases significantly during recovery (Figure 3). The under-
lying mechanism for this increased brain volume remains
unclear and large-scale analyses including serial imaging
and evaluation of diffusion-weighted imaging findings, as
well as clinical, retinopathy and electro-encephalographic
data collection during the acute coma phase and at both
short and long term follow-up are ongoing and aimed
at addressing these questions.
Interestingly, a high-field (3.0 Tesla) MRI series of acute
uncomplicated falciparum malaria patients from Thailandrecently reported that four out of 10 patients presented a
lesion with restricted water diffusion in the splenium of
the corpus callosum [66]. These lesions were transient
and similar in signal and location to some described in CM
patients from the Malaŵi study [65], showing for the first
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sence of the neurologic syndrome. Using diffusion-weighted
imaging to compare the intensity of these lesions between
acute uncomplicated patients and CM patients both in
larger paediatric and adult populations may, therefore,
represent a major step in elucidating mechanisms under-
lying the pathophysiology of CM.
While the systematic application of MRI techniques
to CM patients represents a revolutionary new ap-
proach, there are predictable limitations. For instance,
it is entirely possible that factors inherent in the clin-
ical presentation of the patients directly or indirectly effect
quantitative MRI imaging and confound the investigation
of CM pathogenesis. The multiple organ failure commonly
observed in adult patients with CM in Asia is a complica-
tion that may lead to systematic changes, possibly resulting
in MRI signatures not associated with the occurrence of
the cerebral syndrome. Discriminating between “pure” CM
patients, with no associated complications, and “broad”
CM patients, with one or more associated complications,
may help circumvent this potential bias. In addition,
the MRI scan length also presents potential clinical
management issues, especially when the full sequence
includes perfusion and spectroscopy analyses. While
this is unlikely to be problematic in stable comatose
patients, it might prove challenging in closely moni-
tored patients, as well as pre-comatose ones. Finally,
the use of gadolinium-based contrast agents needs to
be assessed rigorously. For safety issues, it cannot be used
in patients with acute renal failure, a common complica-
tion of severe P. falciparum infection in adults. Alterna-
tive contrast agents have recently become available and
could allow the MRI analysis of such patients in the future.
All of these limiting factors need to be carefully considered
for any prospective study of CM patients using MRI
techniques.
Conclusions
Magnetic resonance examination of both adult and paediat-
ric patients infected with P. falciparum could represent a
major milestone in the study of CM pathology. Until now,
a comparison of both age groups has not been performed,
despite the distinct differences in terms of clinical course,
pathophysiology and autopsy findings [67]. In terms of MRI
features, the amount of available data is currently fractional
in adult CM due to the small number of reported cases. A
comparison between the Malaŵi series and these reports
would, therefore, be uninformative, owing to i) the lack of
protocol and sequence standardization between the differ-
ent sites, ii) the great disparity in patient numbers and iii)
the subacute nature of the MRI studies in adults.
In order to circumvent these discrepancies, new col-
laborative efforts between MRI-equipped sites located
in Asia and in Africa are required, with standardizedclinical protocols and using the presence of retinop-
athy as a diagnostic parameter in CM patients. This
will allow not only the clinical characterization of both
paediatric and adult CM through the application of neuro-
logical MRI methods, but also a precise comparison be-
tween carefully clinically defined cohorts of patients from
different age groups and from different continents.
While the magnet used in the Malaŵi series does not
permit the visualization of ring haemorrhages, more mod-
ern systems with higher field strength magnets are now
available in several clinical sites in Asia, allowing increased
resolution, thinner slice imaging, and diffusion imaging,
which should show ischemia, diffusion tensor imaging to
show axons via tractography and damaged white matter
via fractional anisotropy maps, spectroscopy to follow lac-
tate in ischemia, susceptibility weighted imaging which
may reveal haemozoin, and perfusion imaging which may
demonstrate occluded arterioles. Potential pitfalls due to
differences in magnetic field of MRI scanners between
sites can be avoided by using common specific se-
quences. In addition, in order to ensure the accurate
interpretation and comparison of MRI findings in these se-
quences, all the images can be scored and shared between
radiologists via web-based platforms to ensure the highest
diagnosis accuracy [68].
Such extensive MRI techniques have never been applied
systematically to patients with acute complicated or un-
complicated malaria and present a highly promising ap-
proach to further investigate the causal relationship
between brain swelling and the onset of CM. This can be
achieved by assessing MRI patterns supporting or refuting
the potential contribution of key pathogenic mechanisms of
cerebral oedema in patients with CM. Finally, comparison
studies between fatal cases of CM and survivors will,
hopefully, lead to the identification of causes of death.
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